South San Francisco, CA · Founded 2016 · Privately Held (backing)
Developer of curative therapies designed for current gene therapy delivery challenges by systematically screening its proprietary nanoparticle library. BreezeBio is based in South San Francisco, CA and was founded in 2016. Its last reported valuation was $234 million in Feb 2026. It has raised $117 million.
Last reported valuation
$234.0M
Oct 2026
Priced at
—
Total raised
$117.0M
Last round
—
Cap table — not yet on record
BreezeBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BreezeBio with a free account
·The complete investor list: 39 names
·Watch BreezeBio: the Monday email on marks, rounds and moves
